Please use this identifier to cite or link to this item:
|Title:||Carcinoma Ex-pleomorphic Adenoma Derived From Recurrent Pleomorphic Adenoma Shows Important Difference By Array Cgh Compared To Recurrent Pleomorphic Adenoma Without Malignant Transformation|
|Title Alternative:||Carcinoma Ex-adenoma Pleomórfico Derivado De Adenoma Pleomórfico Recorrente Mostra Diferença Importante Por Array Cgh Em Comparação Com Adenoma Pleomórfico Recorrente Sem Transformação Maligna|
Del Negro A.
|Abstract:||A key step of cancer development is the progressive accumulation of genomic changes resulting in disruption of several biological mechanisms. Carcinoma ex-pleomorphic adenoma (CXPA) is an aggressive neoplasm that arises from a pleomorphic adenoma. CXPA derived from a recurrent PA (RPA) has been rarely reported, and the genomic changes associated with these tumors have not yet been studied. Objective We analyzed CXPA from RPAs and RPAs without malignant transformation using array-comparative genomic hybridization (array-CGH) to identify somatic copy number alterations and affected genes. Methods DNA samples extracted from FFPE tumors were submitted to array-CGH investigation, and data was analyzed by Nexus Copy Number Discovery Edition v.7. Results No somatic copy number alterations were found in RPAs without malignant transformation. As for CXPA from RPA, although genomic profiles were unique for each case, we detected some chromosomal regions that appear to be preferentially affected by copy number alterations. The first case of CXPA-RPA (frankly invasive myoepithelial carcinoma) showed copy number alterations affecting 1p36.33p13, 5p and chromosomes 3 and 8. The second case of CXPA-RPA (frankly invasive epithelial-myoepithelial carcinoma) showed several alterations at chromosomes 3, 8, and 16, with two amplifications at 8p12p11.21 and 12q14.3q21.2. The third case of CXPA-RPA (minimally invasive epithelial-myoepithelial carcinoma) exhibited amplifications at 12q13.3q14.1, 12q14.3, and 12q15. Conclusion The occurrence of gains at chromosomes 3 and 8 and genomic amplifications at 8p and 12q, mainly those encompassing the HMGA2, MDM2, WIF1, WHSC1L1, LIRG3, CDK4 in CXAP from RPA can be a significant promotional factor in malignant transformation. © 2016 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial|
Carcinoma Ex-pleomorphic Adenoma
Recurrent Pleomorphic Adenoma
Somatic Copy Number Alterations
|Editor:||Elsevier Editora Ltda|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.